CN101652358A - 新型晶体贝他斯汀金属盐水合物、它的制备方法和包含它的药物组合物 - Google Patents
新型晶体贝他斯汀金属盐水合物、它的制备方法和包含它的药物组合物 Download PDFInfo
- Publication number
- CN101652358A CN101652358A CN200880010709A CN200880010709A CN101652358A CN 101652358 A CN101652358 A CN 101652358A CN 200880010709 A CN200880010709 A CN 200880010709A CN 200880010709 A CN200880010709 A CN 200880010709A CN 101652358 A CN101652358 A CN 101652358A
- Authority
- CN
- China
- Prior art keywords
- bepotastine
- metal salt
- salt hydrate
- crystalline
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
贝他斯汀盐中包含的金属 | X-RPD图谱的衍射角(2θ) | 吸湿性 |
钠 | 6.2,6.8,9.4,15-25(宽峰),31.6 | 吸湿性 |
钾 | 6.3,9.4,15.7,18.8,27.4,28.3 | 吸湿性 |
镁 | 未测定 | 吸湿性 |
锌 | 11.0,22.2,24.7,28.2,32.9,33.5 | 吸湿性 |
L-精氨酸 | 无定形 | 吸湿性 |
L-赖氨酸 | 无定形 | 吸湿性 |
Claims (15)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070033756 | 2007-04-05 | ||
KR1020070033756A KR100878698B1 (ko) | 2007-04-05 | 2007-04-05 | 결정형의 베포타스틴 금속염 수화물, 이의 제조방법 및이를 포함하는 약학 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101652358A true CN101652358A (zh) | 2010-02-17 |
Family
ID=39831122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200880010709A Pending CN101652358A (zh) | 2007-04-05 | 2008-04-04 | 新型晶体贝他斯汀金属盐水合物、它的制备方法和包含它的药物组合物 |
Country Status (9)
Country | Link |
---|---|
US (1) | US20100137367A1 (zh) |
EP (1) | EP2144896A4 (zh) |
JP (1) | JP2010522747A (zh) |
KR (1) | KR100878698B1 (zh) |
CN (1) | CN101652358A (zh) |
AU (1) | AU2008235668A1 (zh) |
CA (1) | CA2682822A1 (zh) |
TW (1) | TW200900392A (zh) |
WO (1) | WO2008123701A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100879409B1 (ko) * | 2007-06-11 | 2009-01-19 | 한미약품 주식회사 | (s)-베포타스틴의 제조방법 및 이에 사용되는 중간체 |
KR101307712B1 (ko) | 2008-12-02 | 2013-09-11 | 한미사이언스 주식회사 | 결정형의 베포타스틴 금속염 수화물, 이의 제조방법 및 이를 포함하는 약학 조성물 |
JP2011195500A (ja) * | 2010-03-19 | 2011-10-06 | Tokuyama Corp | (s)−4−[4−[(4−クロロフェニル)(2−ピリジル)メトキシ]ピペリジノ]ブタン酸一ベンゼンスルホン酸塩の製造方法 |
CN103260623B (zh) * | 2010-10-06 | 2016-11-02 | 伊斯塔制药公司 | 贝托斯汀组合物 |
KR101546596B1 (ko) * | 2011-01-04 | 2015-08-21 | 이스타 파머슈티컬즈, 인크. | 베포타스틴 조성물 |
US9800605B2 (en) * | 2015-01-30 | 2017-10-24 | Securonix, Inc. | Risk scoring for threat assessment |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW486475B (en) | 1996-12-26 | 2002-05-11 | Ube Industries | Acid addition salt of optically active piperidine compound and process for preparing the same |
JP3909998B2 (ja) * | 2000-03-22 | 2007-04-25 | 田辺製薬株式会社 | 経口投与製剤 |
JP2002212067A (ja) * | 2001-01-15 | 2002-07-31 | Taisho Pharmaceut Co Ltd | 風邪治療用組成物 |
EP1391201A4 (en) * | 2001-05-25 | 2004-06-30 | Ssp Co Ltd | MEDICAL COMPOSITIONS |
KR101067795B1 (ko) * | 2002-08-30 | 2011-09-27 | 니코메드 게엠베하 | 알레르기성 비염을 치료하기 위한 사이클레소나이드 및 항히스타민제의 조합물의 용도 |
-
2007
- 2007-04-05 KR KR1020070033756A patent/KR100878698B1/ko active IP Right Grant
-
2008
- 2008-04-03 TW TW097112166A patent/TW200900392A/zh unknown
- 2008-04-04 AU AU2008235668A patent/AU2008235668A1/en not_active Abandoned
- 2008-04-04 CN CN200880010709A patent/CN101652358A/zh active Pending
- 2008-04-04 WO PCT/KR2008/001912 patent/WO2008123701A1/en active Application Filing
- 2008-04-04 JP JP2010500837A patent/JP2010522747A/ja not_active Withdrawn
- 2008-04-04 US US12/531,003 patent/US20100137367A1/en not_active Abandoned
- 2008-04-04 EP EP08741162A patent/EP2144896A4/en not_active Withdrawn
- 2008-04-04 CA CA002682822A patent/CA2682822A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2008235668A1 (en) | 2008-10-16 |
CA2682822A1 (en) | 2008-10-16 |
EP2144896A4 (en) | 2011-06-29 |
US20100137367A1 (en) | 2010-06-03 |
JP2010522747A (ja) | 2010-07-08 |
EP2144896A1 (en) | 2010-01-20 |
WO2008123701A1 (en) | 2008-10-16 |
TW200900392A (en) | 2009-01-01 |
KR100878698B1 (ko) | 2009-01-13 |
KR20080090661A (ko) | 2008-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101652358A (zh) | 新型晶体贝他斯汀金属盐水合物、它的制备方法和包含它的药物组合物 | |
BR122013033343B1 (pt) | Dimaleato de 4-[(3-cloro-4-fluorfenil)amino]-6-{[4-(n,n-dimetilamino)-1-oxo-2-buten-1-il]amino} -7-((s)-tetraidrofuran-3-ilóxi)-quinazolina, seu uso e seu processo de preparação, e composições farmacêuticas | |
JP2011506374A (ja) | テノホビルジソプロキシルの固形物 | |
US9102629B2 (en) | Polymorphic forms of 4-phenylamine quinazoline derivative, the preparation method and uses thereof | |
US7759481B2 (en) | Solid state forms of 5-azacytidine and processes for preparation thereof | |
PT2448945E (pt) | Formas cristalinas de sais de prasugrel | |
RU2485121C1 (ru) | Новые кристаллические формы адефовира дипивоксила и способы его получения | |
CN113816951B (zh) | 吗啉衍生物的盐及其晶型、其制备方法及药物组合物、用途 | |
KR100878140B1 (ko) | 아토바스타틴의 스트론튬염 또는 이의 수화물, 및 이를포함하는 약학 조성물 | |
JP2018515454A (ja) | 尿酸輸送体阻害剤のナトリウム塩およびその結晶形 | |
CN108264465B (zh) | 盐酸达泊西汀一水合物及其制备方法和用途 | |
US20220009929A1 (en) | Polymorphic forms of ibrutinib | |
EP3315493B1 (en) | Phenyl amino pyrimidine compound or polymorph of salt thereof | |
KR101307712B1 (ko) | 결정형의 베포타스틴 금속염 수화물, 이의 제조방법 및 이를 포함하는 약학 조성물 | |
EP3517529B1 (en) | Salt of quinazoline derivative, preparation method therefor and application thereof | |
KR0180566B1 (ko) | 2-아미노-6-플루오로-9-(2-하이드록시에톡시메틸)퓨린 에스테르 유도체 | |
AU2013231084B2 (en) | The polymorphs of 4-anilinoquinazoline derivatives, the preparation methods and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1141290 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: HANMI PHARMACEUTICAL INDUSTRIAL CO., LTD. Free format text: FORMER OWNER: HANMI PHARM. CO., LTD. Effective date: 20110315 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: GYEONGGI, SOUTH KOREA TO: SEOUL, SOUTH KOREA |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20110315 Address after: Seoul, South Kerean Applicant after: Hanmi Pharm Ind Co.,Ltd. Address before: Gyeonggi Do, South Korea Applicant before: Hanmi Pharm. Co., Ltd. |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20100217 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1141290 Country of ref document: HK |